Hypomethylating agent induction therapy followed by hematopoietic cell transplantation is feasible in patients with myelodysplastic syndromes. (Q43115411)
Jump to navigation
Jump to search
scientific article published in January 2010
Language | Label | Description | Also known as |
---|---|---|---|
English | Hypomethylating agent induction therapy followed by hematopoietic cell transplantation is feasible in patients with myelodysplastic syndromes. |
scientific article published in January 2010 |
Statements
Hypomethylating agent induction therapy followed by hematopoietic cell transplantation is feasible in patients with myelodysplastic syndromes (English)
Christopher R Cogle
Iman Imanirad
Laura E Wiggins
Jack Hsu
Randy Brown
Juan C Scornik